用于持续局部药物输送的 κ-Carrageenan / 基比格尔:设计,表征和氨酸释放
Hazal Şatır1, Tülay Selin Erkut2, Demet Çakır2
1Graduate School of Science and Engineering, Bioengineering Division, Hacettepe University, Ankara, Turkey.
International journal of biological macromolecules
|March 7, 2026
概括
这项研究开发了一种新型的kappa-Carrageenan (κ-CA) / Aloe vera bigel,用于控制局部药物输送. 优化的Bigel系统表现出增强的皮肤透性和稳定性,用于黑激素的输送.
科学领域:
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
- 生物技术是生物技术.
背景情况:
- 局部药物输送面临着药物的生物可用性和受控释放的挑战.
- 像黑激素这样的两性化合物具有较低的生物可用性,需要先进的输送系统.
- 比格尔系统提供了一个有前途的平台,可以将水友和脂友成分结合起来,以改善药物输送.
研究的目的:
- 开发和表征一种新的卡帕-卡拉吉南 (κ-CA) /基大系统,用于控制局部药物输送.
- 为了评估使用美拉托尼作为模拟两性药物的比格尔系统的性能.
- 评估开发的BIGEL配方的稳定性,药物释放动力学和皮肤透性.
主要方法:
- 比格尔是通过混合 κ-CA / Vera 水凝和 Vera 机凝以不同的比例来制备的.
- 进行了形态学,物理学,化学学,机械学和学分析,以表征大牛的特征.
- 在体外药物释放和体外皮肤透研究中使用了黑素.
主要成果:
- 70:30 (水凝:有机凝) 的比率产生了具有最佳特性 (例如,~300微米滴,95%的油结合能力,67°C点) 的稳定大.
- 在细胞培养研究中,大的配方是无毒的.
- 在试验室释放显示了5天内约0.36毫克的黑激素,遵循希古奇和科尔斯迈耶-佩帕斯模型.
- 活体研究表明,肌肤透率提高,约0.33毫克的黑激素在24小时内穿过角层.
结论:
- 该 κ-CA / 花大系统是一个稳定和有效的平台,用于控制局部输送的两性药物.
- 优化的比格尔配方增强了通过皮肤角层的药物透.
- 这种创新的Bigel系统有可能提高生物可用性较差的局部药物的治疗疗效.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
68
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
68
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
288
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
288
Modified-Release Drug Delivery Systems: Site-Targeted
59
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
59
Ophthalmic Drug Delivery Systems
126
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
126
Drug Delivery Systems: Different Types
136
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
136
Drug Delivery: Overview
1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K


